Mazama Capital Management’s Edwards Lifesciences EW Stock Holding History

Mazama Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-139,116	Closed	-$3.66M	–	53
2015 Q4	$3.66M	Buy	139,116 +18,696	+16%	+$486K	0.67%	47
2015 Q3	$2.85M	Buy	120,420 +82,812	+220%	+$2M	0.59%	49
2015 Q2	$893K	Buy	37,608 +13,944	+59%	+$315K	0.18%	134
2015 Q1	$562K	Buy	+23,664	New	+$531K	0.12%	179
2013 Q4	–	Sell	-141,096	Closed	-$1.64M	–	255
2013 Q3	$1.64M	Sell	141,096 -37,884	-21%	-$443K	0.89%	35
2013 Q2	$2M	Buy	+178,980	New	+$2.12M	1.25%	27

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mazama Capital Management's EW Position: Q1 2016 in Review

Mazama Capital Management sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 139,116 shares — an estimated $3.66M sold.

Mazama Capital Management first reported a position in EW in Q2 2013 and held it in 6 quarters. The position peaked at $3.66M in Q4 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

Mazama Capital Management reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 139,116 Edwards Lifesciences shares in Q1 2016, an estimated $3.66M.
Mazama Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 6 quarters.
Mazama Capital Management's Edwards Lifesciences position peaked at $3.66M in Q4 2015.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.